Prophylactic parathyroidectomy for familial parathyroid carcinoma;Das familiäre nebenschilddrüsenkarzinom. Indikation zur prophylaktischen parathyreoidektomie?

Chirurg

Volumn 77, Issue 1, 2006, Pages 15-24

  Gimm, O ^a   Lorenz, K ^a   Nguyen Thanh, P ^a   Schneyer, U ^b   Bloching, M ^a   Howell, V M ^c   Marsh, D J ^c   Teh, B T ^d   Krause, U ^a   Dralle, H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Endokrinologie Klinik für Innere Medizin II   (Germany)

^c UNIVERSITY OF SYDNEY   (Australia)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Familial; Hereditary; Parathyroid carcinoma; Parathyroidectomy

Indexed keywords

GENETIC SCREENING; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; PARATHYROID GLAND; PARATHYROID TUMOR; PARATHYROIDECTOMY; PATHOLOGY; PRIMARY HYPERPARATHYROIDISM; REVIEW; RISK ASSESSMENT; SYNDROME;

DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; HUMANS; HYPERPARATHYROIDISM, PRIMARY; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RISK ASSESSMENT; SYNDROME;

EID: 31144476152     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-005-1110-2     Document Type: Review

References (64)

1. Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17 Suppl 2: N18-23
2. Brandi ML, Falchetti A (2004) Genetics of primary hyperparathyroidism. Urol Int 72 Suppl 1:11-16
3. Brandi ML, Gagel RF, Angeli A et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
4. Carling T, Szabo E, Bai M et al. (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85:2042-2047
5. Carling T, Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27-37
6. Carpten JD, Robbins CM, Villablanca A et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680
7. Cavaco BM, Guerra L, Bradley KJ et al. (2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747-1752
8. Cetani F, Pardi E, Borsari S et al. (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583-5591
9. Cetani F, Pardi E, Giovannetti A et al. (2002) Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 56:457-454
10. Chandrasekharappa SC, Guru SC, Manickam P et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407
11. Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT (2003) Hyperparathyroidism-jaw tumour syndrome. J Intern Med 253:634-642
12. Chen Q, Kaji H, Nomura R, Sowa H et al. (2003) Trial to predict malignancy of affected parathyroid glands in primary hyperparathyroidism. Endocr J 50:527-534
13. Dinnen JS, Greenwoood RH, Jones JH, Walker DA, Williams ED (1977) Parathyroid carcinoma in familial hyperparathyroidism. J Clin Pathol 30:966-975
14. Dionisi S, Minisola S, Pepe J, De Geronimo S, Paglia F, Memeo L, Fitzpatrick LA (2002) Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc 77:866-869
15. Donis-Keller H, Dou S, Chi D et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856
16. Dralle H, Sekulla C, Haerting J et al. (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310-1322
17. Eng C, Clayton D, Schuffenecker I et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575-1579
18. Fujikawa M, Okamura K, Sato K, Mizokami T, Tamaki K, Yanagida T, Fujishima M (1998) Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps. Eur J Endocrinol 138:557-561
19. Fuleihan Gel H (2002) Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 17 Suppl 2: N51-56
20. Gertner ME, Kebebew E (2004) Multiple endocrine neoplasia type 2. Curr Treat Options Oncol 5:315-325
21. Gibril F, Schumann M, Pace A, Jensen RT (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83:43-83
22. Gimm O (2001) Multiple endocrine neoplasia type 2: clinical aspects. Front Horm Res 28:103-130
23. Hamill J, Maoate K, Beasley SW, Corbett R, Evans J (2002) Familial parathyroid carcinoma in a child. J Paediatr Child Health 38:314-317
24. Haven CJ, Wong FK, van Dam EW et al. (2000) A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 85:1449-1454
25. Heath DA (2000) Familial hypocalciuric hypercalcemia. Rev Endocr Metab Disord 1:291-296
26. Hendy GN (2000) Molecular mechanisms of primary hyperparathyroidism. Rev Endocr Metab Disord 1:297-305
27. Hobbs MR, Pole AR, Pidwirny GN et al. (1999) Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. Am J Hum Genet 64:518-525
28. Howell VM, Haven O, Kahnoski K et al. (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657-663
29. Howell VM, Zori RT, Stalker HJ et al. (2004) A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones. J Pediatr 145:567
30. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538-544
31. Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88:223-228
32. Jackson CE, Norum RA, Boyd SB, Talpos GB, Wilson SD, Taggart RT, Mallette LE (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006-1012; discussion 1012-1003
33. Jenkins PJ, Satta MA, Simmgen M et al. (1997) Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin Endocrinol (Oxf) 47:747-751
34. Jorde R, Bonaa KH, Sundsfjord J (2000) Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol 53:1164-1169
35. Kakinuma A, Morimoto I, Nakano Y et al. (1994) Familial primary hyperparathyroidism complicated with Wilms' tumor. Intern Med 33:123-126
36. Kassem M, Kruse TA, Wong FK, Larsson C, Teh BT (2000) Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab 85:165-167
37. Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, Perrier ND (2005) Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol 12:260-266
38. Koea JB, Shaw JH (1999) Parathyroid cancer: biology and management. Surg Oncol 8:155-165
39. Levin KE, Galante M, Clark OH (1987) Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery 101:649-660
40. Moon SD, Park JH, Kim EM et al. (2005) A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism- jaw tumor syndrome. J Clin Endocrinol Metab 90:878-883
41. Mulligan LM, Kwok JBJ, Healey CS et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
42. Obara T, Fujimoto Y (1991) Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg 15:738-744
43. Poisson A, Zablewska B, Gaudray P (2003) Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett 189:1-10
44. Rosen IB, Palmer JA (1981) Fibroosseous tumors of the facial skeleton in association with primary hyperparathyroidism: an endocrine syndrome or coincidence? Am J Surg 142:494-498
45. Rubello D, Casara D, Dwamena BA, Shapiro B (2001) Parathyroid carcinoma. A concise review. Minerva Endocrinol 26:59-64
46. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724-731
47. Schuffenecker I, Virally-Monod M, Brohet R et al. (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'étude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83:487-491
48. Shattuck TM, Valimaki S, Obara T et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-1729
49. Silverberg SJ, Bilezikian JP (1996) Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 81:2036-2040
50. Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN, Marx SJ (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81:1-26
51. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96-102
52. Streeten EA, Weinstein LS, Norton JA et al. (1992) Studies in a kindred with parathyroid carcinoma. J Clin Endocrinol Metab 75:362-366
53. Teh BT, Esapa CT, Houlston R et al. (1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am J Hum Genet 63:1544-1549
54. Teh BT, Farnebo F, Kristoffersson U et al. (1996) Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81:4204-4211
55. Teh BT, Farnebo F, Twigg S et al. (1998) Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 83:2114-2120
56. Villablanca A, Calender A, Forsberg L et al. (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41: e32
57. Warner J, Epstein M, Sweet A et al. (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41:155-160
58. Wassif WS, Farnebo F, Teh BT et al. (1999) Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) 50:191-196
59. Wassif WS, Moniz CF, Friedman E et al. (1993) Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77:1485-1489
60. Weinstein LS, Simonds WF (2003) HRPT2, a marker of parathyroid cancer. N Engl J Med 349:1691-1692
61. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF (2005) Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24:1272-1276
62. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA (1992) Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 71:197-205
63. Yamashita K, Suzuki S, Yumita W et al. (2001) A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer. Endocr J 48:453-458
64. Yoshimoto K, Endo H, Tsuyuguchi M et al. (1998) Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features. Clin Endocrinol (Oxf) 48:67-72